+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Rheumatological patients undergoing immunosuppressive treatments and parasitic diseases: a review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections



Rheumatological patients undergoing immunosuppressive treatments and parasitic diseases: a review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections



Clinical and Experimental Rheumatology 32(4): 587-596



Nowadays, several potent immunosuppressive drugs are available for patients with rheumatologic disorders. In general, these treatments are acceptably well tolerated. Nevertheless, in patients with rheumatic diseases, who are taking immunosuppressive drugs, an increased risk of bacterial, viral and fungal, as well as parasitic infections, exists. We have reviewed literature, on PubMed library, on the topic 'parasitic infections in rheumatic disease patients treated with immunosuppressive drugs, including biological therapies'. We used no language or time restrictions. Search was concluded on January 15th 2014. We grouped all parasitic events among rheumatologic, therapeutically immuosuppressed, patients to estimate the magnitude of this risk. Then we gave our viewpoint in the perspective to screen and follow-up for active and latent chronic parasitoses, developing an hypothetical flow-chart. From data published in the literature the real burden of parasitoses, among patients with rheumatic diseases treated with immunosuppressive treatments, can not be estimated. Nevertheless, a positive trend on publication number exists, probably due to more than one reason: i) the increasing number of patients treated, especially with more than one immunosuppressive treatment, including new biological agents; ii) the increasing number of individuals who move from the north to the south of the world (endemic areas for parasitic infections) and vice versa, due to globalisation, and iii) the fact that more attention is paid for notification/publication of cases. Considering parasitic infections as emerging and potentially serious in their evolution, additional strategies for the prevention, careful screening and follow-up, with a high level of suspicion, identification, and pre-emptive therapy are necessary in candidate patients for biological agents.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055569462

Download citation: RISBibTeXText

PMID: 25065776


Related references

Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections. Transplant Infectious Disease 19(2):, 2017

Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review. Clinical Rheumatology 33(4): 577-586, 2014

Effect of therapy using combination of immunosuppressive agents in active chronic hepatitis--report of 2 cases and a review of the literature. Nihon Rinsho. Japanese Journal of Clinical Medicine 30(3): 853-859, 1972

Immunotherapy, Cancer and Rheumatological Diseases: A Review of the Literature and a Series of Cases in a University Hospital. Reumatologia Clinica 2018:, 2018

Demonstration of active and latent Epstein-Barr virus and human herpesvirus-6 infections in bone marrow cells of patients with myelodysplasia and chronic myeloproliferative diseases. In Vivo 8(4): 533-542, 1994

Chronic leg ulcers in adult patients with rheumatological diseases - a 7-year retrospective review. International Wound Journal 11(6): 601-604, 2014

Musculocutaneous chronic graft-versus-host disease: MRI follow-up of patients undergoing immunosuppressive therapy. Ajr. American Journal of Roentgenology 192(5): 1401-1406, 2009

Clinical outcomes of elderly patients undergoing chronic peritoneal dialysis: experiences from one center and a review of the literature. International Urology and Nephrology 39(4): 1295-1302, 2007

Aspergillosis in systemic diseases treated with steroids and/or immunosuppressive drugs: report of 9 cases and review of the literature. La Revue de Medecine Interne 27(11): 813-827, 2006

Aspergillosis in systemic diseases treated with steroids and/or immunosuppressive drugs: report of 9 cases and literature review. Revue de Medecine Interne 27(11): 813-827, 2006

Long-term clinical spectrum and circulating RAS evaluation of anephric patients undergoing hemodialysis: A report of four cases and literature review. JournaloftheRenin-Angiotensin-AldosteroneSystem19(3):1470320318799904, 2018

Respiratory pathology of immunosuppressive drugs. Pulmonary infections during immunosuppressive treatments in patients with renal transplants. Revue de Tuberculose et de Pneumologie 36(5): 763-784, 1972

Acute leukemia and immunosupressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases. Archives of Internal Medicine 139(4): 461-466, 1979

Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis. Thorax 71(1): 64-72, 2016

Management of cytomegalovirus infections in patients treated with immunosuppressive drugs for chronic inflammatory diseases. La Revue de Medecine Interne 29(4): 305-310, 2008